Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
Aiello
L P
LP
Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
D000818:Animals; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D007511:Ischemia / Q000378:metabolism / Q000503:physiopathology; D008222:Lymphokines / Q000037:antagonists & inhibitors / Q000502:physiology*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D017978:Receptors, Growth Factor / Q000378:metabolism; D011975:Receptors, Mitogen / Q000378:metabolism; D040262:Receptors, Vascular Endothelial Growth Factor; D015861:Retinal Neovascularization / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D012171:Retinal Vessels / Q000378:metabolism / Q000503:physiopathology; D015398:Signal Transduction / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D017978:Receptors, Growth Factor; D011975:Receptors, Mitogen; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D020794:Receptor Protein-Tyrosine Kinases; D040262:Receptors, Vascular Endothelial Growth Factor